Involvement of cyclo-oxygenase-1-mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteries

Experimental Physiology

Volumn 97, Issue 2, 2012, Pages 277-289

  Liu, Bin ^a   Luo, Wenhong ^a   Zhang, Yingzhan ^a   Li, Hui ^a   Zhu, Ningxia ^a   Huang, Dongyang ^a   Zhou, Yingbi ^a  

^a SHANTOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLCHOLINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ILOPROST; INDOMETACIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; PROSTACYCLIN; PROSTACYCLIN RECEPTOR; PROSTANOID RECEPTOR; THROMBOXANE PROSTANOID RECEPTOR; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CAROTID ARTERY; CHEMICAL ANALYSIS; CONTROLLED STUDY; EVOKED RESPONSE; FEMALE; FEMORAL ARTERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMETRICS; MALE; MEDIATOR; MESENTERIC ARTERY; METABOLITE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; VASOCONSTRICTION; VASODILATATION; VASOMOTOR REFLEX; WILD TYPE;

EID: 84856423507     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2011.062034     Document Type: Article

References (36)

1. 3 adenosine receptor-mediated contraction through endothelium in mice aorta. Am J Physiol Heart Circ Physiol 293, H3448-H3455.
2. Bolego C, Buccellati C, Prada A, Gaion RM, Folco G & Sala A (2009). Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone. FASEB J 23, 605-612.
3. 2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition. FASEB J 20, 1352-1360.
4. Bunting S, Gryglewski R, Moncada S & Vane JR (1976). Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins 12, 897-913.
5. Catella F, Nowak J & Fitzgerald GA (1986). Measurement of renal and non-renal eicosanoid synthesis. Am J Med 81, 23-29.
6. Davidge ST (2001). Prostaglandin H synthase and vascular function. Circ Res 89, 650-660.
7. Derkach DN, Ihara E, Hirano K, Nishimura J, Takahashi S & Kanaide H (2000). Thrombin causes endothelium-dependent biphasic regulation of vascular tone in the porcine renal interlobar artery. Br J Pharmacol 131, 1635-1642.
8. Egan KM, Lawson JA, Fries S, Koller B, Rader DJ, Smyth EM & Fitzgerald GA (2004). COX-2-derived prostacyclin confers atheroprotection on female mice. Science 306, 1954-1957.
9. FitzGerald GA & Patrono C (2001). The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 345, 433-442.
10. Gauthier KM, Goldman DH, Aggarwal NT, Chawengsub Y, Falck JR & Campbell WB (2011). Role of arachidonic acid lipoxygenase metabolites in acetylcholine relaxations of mouse arteries. Am J Physiol Heart Circ Physiol 300, H725-H735.
11. Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM & Feletou M (2005). Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol 146, 834-845.
12. Grosser T, Fries S & FitzGerald GA (2006). Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116, 4-15.
13. Ihara E, Hirano K, Derkach DN, Nishimura J, Nawata H & Kanaide H (2000). The mechanism of bradykinin-induced endothelium-dependent contraction and relaxation in the porcine interlobar renal artery. Br J Pharmacol 129, 943-952.
14. Ihara E, Hirano K, Nishimura J, Nawata H & Kanaide H (1999). Thapsigargin-induced endothelium-dependent triphasic regulation of vascular tone in the porcine renal artery. Br J Pharmacol 128, 689-699.
15. Katusic ZS & Shepherd JT (1991). Endothelium-derived vasoactive factors: II. Endothelium-dependent contraction. Hypertension 18, III86-III92.
16. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Kim HS & Smithies O (1995). Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83, 483-492.
17. Levy JV (1978). Contractile responses to prostacyclin (PGI2) of isolated human saphenous and rat venous tissue. Prostaglandins 16, 93-97.
18. Levy JV (1980). Prostacyclin-induced contraction of isolated aortic strips from normal and spontaneously hypertensive rats (SHR). Prostaglandins 19, 517-525.
19. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA & Smithies O (1995). Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83, 473-482.
20. Mundy AL, Haas E, Bhattacharya I, Widmer CC, Kretz M, Hofmann-Lehmann R, Minotti R & Barton M (2007). Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity. Cardiovasc Res 73, 368-375.
21. Needleman P, Moncada S, Bunting S, Vane JR, Hamberg M & Samuelsson B (1976). Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature 261, 558-560.
22. Niwa K, Haensel C, Ross ME & Iadecola C (2001). Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation. Circ Res 88, 600-608.
23. Okon EB, Golbabaie A & van Breemen C (2002). In the presence of l-NAME SERCA blockade induces endothelium-dependent contraction of mouse aorta through activation of smooth muscle prostaglandin H2/thromboxane A2 receptors. Br J Pharmacol 137, 545-553.
24. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD & Breyer MD (2002). Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 110, 61-69.
25. 1α in man. Biochim Biophys Acta 619, 207-213.
26. Rudic RD, Brinster D, Cheng Y, Fries S, Song WL, Austin S, Coffman TM & FitzGerald GA (2005). COX-2-derived prostacyclin modulates vascular remodeling. Circ Res 96, 1240-1247.
27. Samuelsson B, Goldyne M, Granstrom E, Hamberg M, Hammarstrom S & Malmsten C (1978). Prostaglandins and thromboxanes. Annu Rev Biochem 47, 997-1029.
28. Shirahase H, Kanda M, Kurahashi K, Nakamura S, Usui H & Shimizu Y (1995). Endothelium-dependent contraction in intrapulmonary arteries: mediation by endothelial NK1 receptors and TXA2. Br J Pharmacol 115, 1215-1220.
29. Smith WL, DeWitt DL & Garavito RM (2000). Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69, 145-182.
30. Sun D, Liu H, Yan C, Jacobson A, Ojaimi C, Huang A & Kaley G (2006). COX-2 contributes to the maintenance of flow-induced dilation in arterioles of eNOS-knockout mice. Am J Physiol Heart Circ Physiol 291, H1429-H1435.
31. -/- knockout mice. J Cardiovasc Pharmacol 46, 761-765.
32. Traupe T, Lang M, Goettsch W, Munter K, Morawietz H, Vetter W & Barton M (2002a). Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens 20, 2239-2245.
33. Traupe T, D'Uscio LV, Muenter K, Morawietz H, Vetter W & Barton M (2002b). Effects of obesity on endothelium-dependent reactivity during acute nitric oxide synthase inhibition: modulatory role of endothelin. Clin Sci (Lond) 103(Suppl 48), 13S-15S.
34. 2α mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging. Circ Res 104, 228-235.
35. 2 and prostacyclin. Br J Pharmacol 154, 1225-1235.
36. Zhou Y, Varadharaj S, Zhao X, Parinandi N, Flavahan NA & Zweier JL (2005). Acetylcholine causes endothelium-dependent contraction of mouse arteries. Am J Physiol Heart Circ Physiol 289, H1027-H1032.